{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:37Z","timestamp":1790806417249,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UK Experimental Arthritis Centre for Children"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.clim.2020.108381","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T20:56:00Z","timestamp":1583787360000},"page":"108381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Juvenile-onset Beh\u00e7et's syndrome and mimics"],"prefix":"10.1016","volume":"214","author":[{"given":"Clare E.","family":"Pain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Behcet syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","article-title":"Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study","volume":"157","author":"Alpsoy","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Behcet's disease: a controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med. J."},{"issue":"9","key":"10.1016\/j.clim.2020.108381_bb0030","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-019-04570-w","article-title":"Behcet's disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature","volume":"38","author":"Gheita","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"6 Suppl 115","key":"10.1016\/j.clim.2020.108381_bb0035","first-page":"135","article-title":"Paediatric Behcet's disease in Iran: report of 204 cases","volume":"36","author":"Shahram","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09273948.2011.555592","article-title":"Behcet disease in children","volume":"19","author":"Atmaca","year":"2011","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Behcet's disease prevalence: a meta-analytical approach","volume":"57","author":"Maldini","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0050","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","article-title":"Paediatric Behcet's disease: a UK tertiary Centre experience","volume":"35","author":"Nanthapisal","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","article-title":"A national cohort study on pediatric Behcet's disease: cross-sectional data from an Italian registry","volume":"15","author":"Gallizzi","year":"2017","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD","volume":"75","author":"Kone-Paut","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1525-1470.1994.tb00559.x","article-title":"Clinical analysis of 40 cases of childhood-onset Behcet's disease","volume":"11","author":"Kim","year":"1994","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","article-title":"Behcet's disease in children, an overview","volume":"14","author":"Kone-Paut","year":"2016","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0075","first-page":"179","article-title":"Behcet's disease in children: single-center experience","volume":"54","author":"Cirkinoglu","year":"2019","journal-title":"Turk. Pediatr. Ars"},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2007.137141","article-title":"Clinical and demographic evaluation of Behcet disease among different paediatric age groups","volume":"93","author":"Sungur","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0085","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet's, D","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8697","key":"10.1016\/j.clim.2020.108381_bb0090","first-page":"1078","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.clim.2020.108381_bb0095","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.3748\/wjg.v21.i13.3801","article-title":"Gastrointestinal Behcet's disease: a review","volume":"21","author":"Skef","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3899\/jrheum.100257","article-title":"Pediatric Behcet's disease and thromboses","volume":"38","author":"Krupa","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2020.108381_bb0105","first-page":"147","article-title":"Paediatric Behcet's disease with sinus venous thrombosis: experience from three centres from Turkey","volume":"37","author":"Demir","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.clim.2020.108381_bb0110","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Behcet's disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2020.108381_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-8-18","article-title":"Neuro-Behcet's disease in childhood: a focus on the neuro-ophthalmological features","volume":"8","author":"Mora","year":"2013","journal-title":"Orphanet. J. Rare Dis."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/rheumatology\/38.5.457","article-title":"Childhood Behcet's disease: clinical features and comparison with adult-onset disease","volume":"38","author":"Krause","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 121(6)","key":"10.1016\/j.clim.2020.108381_bb0125","first-page":"48","article-title":"Comparing the clinical profile of adults and children with Behcet's syndrome in the UK","volume":"37","author":"Makmur","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0130","first-page":"309","article-title":"Behcets disease in children","volume":"39","author":"Pivetti-Pezzi","year":"1995","journal-title":"Jpn. J. Ophthalmol."},{"issue":"3 Suppl 77","key":"10.1016\/j.clim.2020.108381_bb0135","first-page":"64","article-title":"Fever in Behcet's syndrome","volume":"31","author":"Seyahi","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0145","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/1756-185X.12520","article-title":"The saga of diagnostic\/classification criteria in Behcet's disease","volume":"18","author":"Davatchi","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"issue":"Suppl 108(6)","key":"10.1016\/j.clim.2020.108381_bb0150","first-page":"119","article-title":"The performance of different classification criteria in paediatric Behcet's disease","volume":"35","author":"Batu","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6, supplement 115","key":"10.1016\/j.clim.2020.108381_bb0155","article-title":"Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Beh\u00e7et's disease","volume":"36","author":"Pain","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6 Suppl 115","key":"10.1016\/j.clim.2020.108381_bb0160","first-page":"90","article-title":"Faecal but not serum calprotectin levels look promising in predicting active disease in Behcet's syndrome patients with gastrointestinal involvement","volume":"36","author":"Esatoglu","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3899\/jrheum.131249","article-title":"Outcome measures used in clinical trials for Behcet syndrome: a systematic review","volume":"41","author":"Hatemi","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2020.108381_bb0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet's disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0180","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat. Genet."},{"issue":"Suppl 121(6)","key":"10.1016\/j.clim.2020.108381_bb0185","first-page":"3","article-title":"One year in review 2019: Behcet's syndrome","volume":"37","author":"Hatemi","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0190","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat. Genet."},{"issue":"20","key":"10.1016\/j.clim.2020.108381_bb0195","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1073\/pnas.1306352110","article-title":"Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease","volume":"110","author":"Kirino","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13075-018-1613-0","article-title":"GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behcet's disease","volume":"20","author":"Nakano","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.clim.2020.108381_bb0205","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"'MHC-I-opathy'-unified concept for spondyloarthritis and Behcet disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"24","key":"10.1016\/j.clim.2020.108381_bb0210","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.1406575111","article-title":"Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity","volume":"111","author":"Ombrello","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0220","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4049\/jimmunol.1701061","article-title":"Novel transcriptional activity and extensive allelic imbalance in the human MHC region","volume":"200","author":"Gensterblum-Miller","year":"2018","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0225","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.39545","article-title":"Whole exome sequencing identifies rare protein-coding variants in Behcet's disease","volume":"68","author":"Ognenovski","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2020.108381_bb0230","doi-asserted-by":"crossref","first-page":"19456","DOI":"10.1038\/srep19456","article-title":"Microarray and whole-exome sequencing analysis of familial Behcet's disease patients","volume":"6","author":"Okuzaki","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13075-019-1928-5","article-title":"Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behcet's disease","volume":"21","author":"Tsuchida","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0245","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/art.38409","article-title":"Epigenome-wide scan identifies a treatment-responsive pattern of altered DNA methylation among cytoskeletal remodeling genes in monocytes and CD4+ T cells from patients with Behcet's disease","volume":"66","author":"Hughes","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13317-016-0074-1","article-title":"Behcet's disease physiopathology: a contemporary review","volume":"7","author":"Zeidan","year":"2016","journal-title":"Auto Immun. Highlights"},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0255","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1346-8138.2003.tb00442.x","article-title":"Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease","volume":"30","author":"Aridogan","year":"2003","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2006.04.016","article-title":"Intraocular cytokine environment in active Behcet uveitis","volume":"142","author":"Ahn","year":"2006","journal-title":"Am J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.clim.2020.108381_bb0265","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Behcet patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clim.2020.108381_bb0270","doi-asserted-by":"crossref","first-page":"4246965","DOI":"10.1155\/2018\/4246965","article-title":"Gene expression profiling in Behcet's disease indicates an autoimmune component in the pathogenesis of the disease and opens new avenues for targeted therapy","volume":"2018","author":"Puccetti","year":"2018","journal-title":"J Immunol Res"},{"issue":"4 Suppl 60","key":"10.1016\/j.clim.2020.108381_bb0275","first-page":"S16","article-title":"Imbalance of Th17 to Th1 cells in Behcet's disease","volume":"28","author":"Kim","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5 Suppl 24","key":"10.1016\/j.clim.2020.108381_bb0280","first-page":"S19","article-title":"Neutrophil activation in Behcet's disease","volume":"19","author":"Eksioglu-Demiralp","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.clim.2020.108381_bb0285","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1136\/annrheumdis-2018-214335","article-title":"Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease","volume":"78","author":"Le Joncour","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cei.12939","article-title":"Circulating NK cells and their subsets in Behcet's disease","volume":"188","author":"Hasan","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Behcet's syndrome patients exhibit specific microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0300","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s40168-018-0520-6","article-title":"A metagenomic study of the gut microbiome in Behcet's disease","volume":"6","author":"Ye","year":"2018","journal-title":"Microbiome"},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5152\/eurjrheum.2018.18094","article-title":"The assessment of contributing factors to oral ulcer presence in Behcet's disease: dietary and non-dietary factors","volume":"5","author":"Iris","year":"2018","journal-title":"Eur. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0310","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Behcet's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","article-title":"Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet's disease: an international cohort study of 110 patients. One-year follow-up data","volume":"50","author":"Kone-Paut","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0320","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12887-019-1613-5","article-title":"Clinical manifestations and anti-TNF alpha therapy of juvenile Behcet's disease in Taiwan","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.clim.2020.108381_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011018","article-title":"Interventions for the management of oral ulcers in Behcet's disease","volume":"9","author":"Taylor","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0330","first-page":"399","article-title":"A double blind study of colchicine in Behcet's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0335","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.clim.2020.108381_bb0340","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0345","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Behcet's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.clim.2020.108381_bb0350","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of apremilast for oral ulcers in Behcet's syndrome","volume":"381","author":"Hatemi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0355","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/art.40912","article-title":"Long-term outcome of ustekinumab therapy for Behcet's disease","volume":"71","author":"Mirouse","year":"2019","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0360","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-017-1222-3","article-title":"Treatment of mucocutaneous manifestations in Behcet's disease with anakinra: a pilot open-label study","volume":"19","author":"Grayson","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2020.108381_bb0365","article-title":"Biologic therapy for Behcet's uveitis: a systematic review","author":"Uke","year":"2019","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0370","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","volume":"120","author":"Dick","year":"2013","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09273940701299370","article-title":"A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behcet's disease","volume":"15","author":"Buggage","year":"2007","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"7","key":"10.1016\/j.clim.2020.108381_bb0380","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/09273948.2017.1421233","article-title":"Use of gevokizumab in patients with Behcet's disease uveitis: an international, randomized, double-masked, placebo-controlled study and open-label extension study","volume":"26","author":"Tugal-Tutkun","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0385","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int. J. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0390","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0395","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10050","key":"10.1016\/j.clim.2020.108381_bb0400","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clim.2020.108381_bb0405","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/art.41026","article-title":"Comparative study of infliximab versus adalimumab in refractory uveitis due to Behcet's disease: National Multicenter Study of 177 cases","volume":"71","author":"Atienza-Mateo","year":"2019","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-019-0181-z","article-title":"Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis","volume":"9","author":"Ho","year":"2019","journal-title":"J. Ophthal. Inflamm. Infect."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0415","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12969-019-0333-6","article-title":"Early administration of adalimumab for paediatric uveitis due to Behcet's disease","volume":"17","author":"Hiyama","year":"2019","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0420","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00296-019-04300-0","article-title":"Adalimumab in the treatment of pediatric Behcet's disease: case-based review","volume":"39","author":"Poddighe","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0425","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","article-title":"Tocilizumab for severe refractory neuro-Behcet: three cases IL-6 blockade in neuro-Behcet","volume":"44","author":"Addimanda","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"3\u20134","key":"10.1016\/j.clim.2020.108381_bb0430","first-page":"238","article-title":"Efficacy and safety of intravenous immunoglobulin treatment in refractory Behcet's disease with different organ involvement: a case series","volume":"18","author":"Cantarini","year":"2016","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.clim.2020.108381_bb0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jocn.2016.03.020","article-title":"Neuro-Behcet's disease presenting with tumour-like lesions and responding to rituximab","volume":"32","author":"Jade","year":"2016","journal-title":"J. Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.clim.2020.108381_bb0440","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1007\/s00415-015-7897-y","article-title":"Rituximab is effective in severe treatment-resistant neurological Behcet's syndrome","volume":"262","author":"Kidd","year":"2015","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0445","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation","volume":"27","author":"Ahn","year":"2008","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.clim.2020.108381_bb0450","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000494","article-title":"Behcet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0455","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Behcet's disease","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.clim.2020.108381_bb0460","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00431-009-1040-y","article-title":"Behcet disease: treatment of vascular involvement in children","volume":"169","author":"Ozen","year":"2010","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0465","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/MCG.0b013e3182431d56","article-title":"Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with intestinal Behcet disease","volume":"46","author":"Jung","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.clim.2020.108381_bb0470","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5217\/ir.2017.15.3.395","article-title":"Long-term safety and efficacy of adalimumab for intestinal Behcet's disease in the open label study following a phase 3 clinical trial","volume":"15","author":"Inoue","year":"2017","journal-title":"Intest. Res."},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0475","first-page":"748","article-title":"Comparison of clinical features of Behcet disease according to age in a Tunisian cohort","volume":"52","author":"Hamzaoui","year":"2014","journal-title":"Acta Med. Iran"},{"issue":"9","key":"10.1016\/j.clim.2020.108381_bb0480","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/art.27568","article-title":"Mortality in Behcet's disease","volume":"62","author":"Saadoun","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.clim.2020.108381_bb0485","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/rheumatology\/key445","article-title":"Monogenic mimics of Behcet's disease in the young","volume":"58","author":"Papadopoulou","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2020.108381_bb0490","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-kappaB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0495","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jbspin.2018.11.003","article-title":"New data in causes of autoinflammatory diseases","volume":"86","author":"Kone-Paut","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.clim.2020.108381_bb0500","article-title":"Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment","author":"Yu","year":"2019","journal-title":"World J. Pediatr."},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0505","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.clim.2020.108381_bb0510","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.clim.2020.108381_bb0515","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-017-0699-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2), an inherited cause of polyarteritis nodosa and a mimic of other systemic rheumatologic disorders","volume":"19","author":"Hashem","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl 121(6)","key":"10.1016\/j.clim.2020.108381_bb0520","first-page":"142","article-title":"Phenotypic variability including Behcet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A>G splice site mutation","volume":"37","author":"van Well","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2020.108381_bb0525","first-page":"65(4)","article-title":"Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis","author":"Alsultan","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"7","key":"10.1016\/j.clim.2020.108381_bb0530","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0535","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12016-009-8136-z","article-title":"Chronic granulomatous disease","volume":"38","author":"Holland","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.clim.2020.108381_bb0540","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/INF.0b013e3182481ed9","article-title":"Chronic granulomatous disease masquerading as Behcet disease: a case report and review of the literature","volume":"31","author":"Thomsen","year":"2012","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"728","key":"10.1016\/j.clim.2020.108381_bb0545","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/pgmj.62.728.489","article-title":"Chronic granulomatous disease presenting as an oculomucocutaneous syndrome mimicking Behcet's syndrome","volume":"62","author":"Kelleher","year":"1986","journal-title":"Postgrad. Med. J."},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0550","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0555","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3349\/ymj.2016.57.1.22","article-title":"Intestinal Behcet's disease: a true inflammatory bowel disease or merely an intestinal complication of systemic Vasculitis?","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med. J."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0560","first-page":"103","article-title":"Mimicry and deception in inflammatory bowel disease and intestinal behcet disease","volume":"8","author":"Grigg","year":"2012","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"issue":"1","key":"10.1016\/j.clim.2020.108381_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(87)80285-8","article-title":"Syndrome of periodic fever, pharyngitis, and aphthous stomatitis","volume":"110","author":"Marshall","year":"1987","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.clim.2020.108381_bb0570","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.clim.2020.108381_bb0575","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10067-015-2890-5","article-title":"PFAPA syndrome and Behcet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists","volume":"35","author":"Cantarini","year":"2016","journal-title":"Clin. Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661620300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:50Z","timestamp":1761494450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661620300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":115,"alternative-id":["S1521661620300310"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2020.108381","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile-onset Beh\u00e7et's syndrome and mimics","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2020.108381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108381"}}